Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4688933015 | Niraparib tosylate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4688934014 | Niraparib tosylate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Niraparib tosylate | Is a | Piperazine derivative | true | Inferred relationship | Existential restriction modifier | ||
| Niraparib tosylate | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier | ||
| Niraparib tosylate | Is a | Substance with enzyme inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Niraparib tosylate | Is a | Substance with nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Niraparib tosylate | Has disposition | Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Niraparib tosylate | Is modification of | Niraparib | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely niraparib (as niraparib tosylate) 100 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Niraparib tosylate | Inferred relationship | Existential restriction modifier | 1 |
| Niraparib tosylate monohydrate | Is modification of | True | Niraparib tosylate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR